LifePoint Health (NASDAQ:LPNT)‘s stock had its “equal weight” rating reaffirmed by equities research analysts at Morgan Stanley in a research report issued on Monday. They currently have a $46.00 target price on the stock, down from their previous target price of $50.00. Morgan Stanley’s target price suggests a potential downside of 1.71% from the stock’s current price.
Other research analysts have also recently issued reports about the company. BidaskClub raised LifePoint Health from a “sell” rating to a “hold” rating in a research note on Thursday, January 11th. William Blair reissued an “outperform” rating on shares of LifePoint Health in a research note on Tuesday, November 21st. Credit Suisse Group began coverage on LifePoint Health in a research note on Thursday, November 2nd. They set a “neutral” rating and a $54.00 target price for the company. ValuEngine cut LifePoint Health from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. Finally, Robert W. Baird set a $55.00 target price on LifePoint Health and gave the stock a “buy” rating in a research note on Monday, October 30th. One research analyst has rated the stock with a sell rating, fifteen have given a hold rating and five have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $55.00.
Shares of LifePoint Health (NASDAQ:LPNT) opened at $46.80 on Monday. LifePoint Health has a one year low of $41.45 and a one year high of $67.95. The company has a quick ratio of 1.49, a current ratio of 1.70 and a debt-to-equity ratio of 1.26. The firm has a market capitalization of $1,685.03, a price-to-earnings ratio of 19.02, a PEG ratio of 0.98 and a beta of 0.52.
In other LifePoint Health news, insider David M. Dill sold 45,000 shares of LifePoint Health stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $48.52, for a total transaction of $2,183,400.00. Following the completion of the sale, the insider now directly owns 252,673 shares of the company’s stock, valued at approximately $12,259,693.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 8.76% of the stock is owned by insiders.
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Xact Kapitalforvaltning AB purchased a new stake in LifePoint Health during the 4th quarter worth about $230,000. Letko Brosseau & Associates Inc. lifted its holdings in LifePoint Health by 3.1% during the 4th quarter. Letko Brosseau & Associates Inc. now owns 1,429,654 shares of the company’s stock worth $71,197,000 after buying an additional 43,615 shares during the last quarter. MetLife Investment Advisors LLC purchased a new stake in LifePoint Health during the 4th quarter worth about $1,242,000. Gotham Asset Management LLC lifted its holdings in LifePoint Health by 138.3% during the 4th quarter. Gotham Asset Management LLC now owns 161,286 shares of the company’s stock worth $8,032,000 after buying an additional 93,596 shares during the last quarter. Finally, Jane Street Group LLC purchased a new stake in LifePoint Health during the 4th quarter worth about $335,000.
ILLEGAL ACTIVITY WARNING: This news story was reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this news story on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this news story can be accessed at https://www.tickerreport.com/banking-finance/3227145/lifepoint-healths-lpnt-equal-weight-rating-reaffirmed-at-morgan-stanley.html.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.